EXTERNAL PUBLICATION

Safety profile of two novel antiepileptic agents approved for the treatment of refractory partial seizures: ezogabine (retigabine) and perampanel

Michele A Faulkner, Rachel A Burke

July 25, 2013 Expert Opinion on Drug Safety

DOI: 10.1517/14740338.2013.823399

No discussion yet

	Project	Subject	Last comment	Time
11	rephetio	Prediction in epilepsy	Daniel Himmelstein	Jan. 10, 2017